Disposition Kinetics and Tissue Distribution of Titanium Dioxide (TiO2) Nanoparticles Following Single Exposure in Male Wistar Rats
DOI:
https://doi.org/10.18311/ti/2024/v31i1/34886Keywords:
Nanoparticles, Toxicokinetics, Titanium Dioxide (TiO2), Wistar RatsAbstract
Titanium Dioxide (TiO2) nanoparticles are one among the several environmental contaminants essentially due to their widespread applications in food, medicine, cosmetics, electronics, and several other applications. The current experimental study was undertaken to determine the toxicokinetic variables and tissue distribution profile of titanium (Ti) following single intraperitoneal (i.p) administration of titanium dioxide nanoparticles (TiO2 NPs) in male Wistar rats. The Tmax(obs.), Cmax (obs.), the elimination half-life (t1/2k10), the area under the curve (AUC0-336), and AUC0-∞ of TiO2 following single i.p administration of TiO2 NPs in whole blood was 0.5h, 0.26 ± 0.03 μg.ml-l, 486.31 ± 39.66 h, 48.81 ± 0.54 μg/ml*h and 128.28 ± 7.17 μg/ml*h, respectively. The mean Titanium (Ti) concentration ratio for tissue(s)- to whole blood measured at 336 h as well as the Cmax(obs.) was in the order of liver > spleen > lung > kidney > testis > brain following single i.p administration. The elimination half-life (t1/2k10) was in the order of spleen > kidney > liver > lung. The toxicokinetic and tissue distribution profile TiO2 NPs thus derived would serve as baseline data to execute long-term studies with toxicoepidemiological relevant concentration so as to re-visit safety pharmacology governing TiO2 -nanoparticles exposure from various sources including pharmaceuticals.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 G. R. Shivaprasad, Nadoor Prakash, Prashant Kumar Waghe, B. H. Pavithra, C. R. Santhosh, Rashmi Rajashekaraiah, Y. Muralidhar, T. N. V. K. V. Prasad, U. Sunilchandra, M. Vijaykumar, S. S. Manjunath, K. Vaibhavi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Accepted 2023-12-26
Published 2024-02-28
References
Zhao J, Castranova V. Toxicology of nanomaterials used in nanomedicine. J Toxicol Environ Health B Crit Rev. 2011; 14(8):593-632. PMID: 22008094. https://doi.org/10.1080/1 0937404.2011.615113 DOI: https://doi.org/10.1080/10937404.2011.615113
Iavicoli I, Leso V, Bergamaschi. A toxicological effects of titanium dioxide nanoparticles: A review of in-vivo studies. J Nanomater. 2012. PMiD 964381. https://doi. org/10.1155/2012/964381 DOI: https://doi.org/10.1155/2012/964381
Shi H, Magaye R, Castranova V, Zhao J. Titanium dioxide nanoparticles: A review of current toxicological data. Part Fibre Toxicol. 2013; 10:15. PMID: 23587290. https://doi. org/10.1186/1743-8977-10-15 DOI: https://doi.org/10.1186/1743-8977-10-15
Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Cogliano V. Carcinogenicity of carbon black, titanium dioxide, and talc. Lancet Oncol. 2006; 7(4):295-6. PMID: 16598890. https://doi.org/10.1016/S1470-2045(06)70651-9 DOI: https://doi.org/10.1016/S1470-2045(06)70651-9
Weir A, Westerhoff P, Fabricius L, Hristovski K, Von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol. 2012; 46(4):2242-50. PMID: 22260395. https://doi.org/10.1021/es204168d DOI: https://doi.org/10.1021/es204168d
Winkler HC, Notter T, Meyer U, Naegeli H. Critical review of the safety assessment of titanium dioxide additives in food. J Nanobiotechnology. 2018; 16(1):51. PMID: 29859103. https://doi.org/10.1186/s12951-018-0376-8 DOI: https://doi.org/10.1186/s12951-018-0376-8
Song Y, Li X, Du X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis, and granuloma. Eur Respir J. 2009; 34(3):559-67. PMID: 19696157. https://doi. org/10.1183/09031936.00178308 DOI: https://doi.org/10.1183/09031936.00178308
Shabbir S, Kulyar MF, Bhutta ZA, Boruah P, Asif M. Toxicological consequences of titanium dioxide nanoparticles (TiO2NPs) and their Jeopardy to the human population. Bionanoscience. 2021; 11(2):621-32. PMID: 33520589. https://doi.org/10.1007/s12668-021-00836-3 DOI: https://doi.org/10.1007/s12668-021-00836-3
Rashid MM, Forte Tavcer P, Tomsic B. Influence of titanium dioxide nanoparticles on human health and the environment. Nanomater (Basel). 2021; 11(9):2354. PMID: 34578667. https://doi.org/10.3390/nano11092354 DOI: https://doi.org/10.3390/nano11092354
Zhang X, Yin L, Tang M, Pu Y. Optimized method for preparation of TiO2 nanoparticles dispersion for biological study. J Nanosci Nanotechnol. 2010; 10(8):5213-9. PMID: 21125873. https://doi.org/10.1166/jnn.2010.2397 DOI: https://doi.org/10.1166/jnn.2010.2397
Golasik M, Herman M, Olbert M, Librowski T, Szklarzewicz J, Piekoszewski W. Toxicokinetics and tissue distribution of titanium in ionic form after intravenous and oral administration. Toxicol Lett. 2016; 247:56-61. PMID: 26892718. https://doi.org/10.1016/j.toxlet.2016.02.009 DOI: https://doi.org/10.1016/j.toxlet.2016.02.009
Elgrabli D, Beaudouin R, Jbilou N, Floriani M, Pery A, Rogerieux F, Lacroix G. Biodistribution and clearance of TiO2 nanoparticles in Rats after intravenous injection. PLoS One. 2015; 10(4):e0124490. PMID: 25909957. https:// doi.org/10.1371/journal.pone.0124490 DOI: https://doi.org/10.1371/journal.pone.0124490
Greenblatt DJ, Abernethy DR, Divoll M. Is the volume of distribution at steady state a meaningful kinetic variable? J Clin Pharmacol. 1983; 23(8-9):391-400. PMID: 6355205. https://doi.org/10.1002/j.1552-4604.1983.tb02753.x DOI: https://doi.org/10.1002/j.1552-4604.1983.tb02753.x
Xie G, Wang C, Sun J, Zhong G. Tissue distribution and excretion of intravenously administered titanium dioxide nanoparticles. Toxicol Lett. 2011; 205(1):55-61. PMID: 21600967. https://doi.org/10.1016/j.toxlet.2011.04.034 DOI: https://doi.org/10.1016/j.toxlet.2011.04.034
Geraets L, Oomen AG, Krystek P, Jacobsen NR, Wallin H, Laurentie M, Verharen HW, Brandon EF, de Jong WH. Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats. Part Fibre Toxicol. 2014; 11:30. PMID: 24993397. https://doi.org/10.1186/1743-8977- 11-30 DOI: https://doi.org/10.1186/1743-8977-11-30
Disdier C, Devoy J, Cosnefroy A, Chalansonnet M, Herlin-Boime N, Brun E, Lund A, Mabondzo A. Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in the rat. Part Fibre Toxicol. 2015; 12:27. PMID: 26337446. https://doi. org/10.1186/s12989-015-0102-8 DOI: https://doi.org/10.1186/s12989-015-0102-8